1. Home
  2. BLRX vs RGS Comparison

BLRX vs RGS Comparison

Compare BLRX & RGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioLineRx Ltd.

BLRX

BioLineRx Ltd.

HOLD

Current Price

$1.20

Market Cap

11.7M

Sector

Health Care

ML Signal

HOLD

Logo Regis Corporation

RGS

Regis Corporation

HOLD

Current Price

$22.47

Market Cap

72.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLRX
RGS
Founded
2003
1922
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
11.7M
72.6M
IPO Year
2010
1994

Fundamental Metrics

Financial Performance
Metric
BLRX
RGS
Price
$1.20
$22.47
Analyst Decision
Analyst Count
0
0
Target Price
★ $22.00
N/A
AVG Volume (30 Days)
8.8K
★ 14.5K
Earning Date
12-01-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.18
Revenue
N/A
★ $224,485,000.00
Revenue This Year
$37.33
N/A
Revenue Next Year
$37.06
$1.68
P/E Ratio
★ N/A
$127.67
Revenue Growth
N/A
★ 6.83
52 Week Low
$1.14
$19.31
52 Week High
$3.95
$32.00

Technical Indicators

Market Signals
Indicator
BLRX
RGS
Relative Strength Index (RSI) 13.10 23.37
Support Level N/A $19.31
Resistance Level $3.04 $29.05
Average True Range (ATR) 0.14 1.38
MACD -0.05 -0.64
Stochastic Oscillator 6.82 0.00

Price Performance

Historical Comparison
BLRX
RGS

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

About RGS Regis Corporation

Regis Corporation franchises, owns, and operates hair care salons, mainly in North America, with licensed locations in the U.K. Its salons provide haircutting, styling, shampooing and conditioning, hair coloring and related services, and also sell hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, Cost Cutters, First Choice Haircutters and Roosters. Its operating segments are Franchise and Company-Owned, with the majority of its revenue generated from the Franchise segment.

Share on Social Networks: